Monte Rosa Therapeutics, Inc
4 clinical trials · Sponsor
◉ Watch Monte Rosa Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Study of Oral MRT-2359 With Apalutamide in Prostate Cancer (NCT07745361) | Monte Rosa Therapeutics, Inc | 2026-08-01 |
| A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP (NCT07119125) | Monte Rosa Therapeutics, Inc | 2025-06-27 |
| First-in-human Study of MRT-6160 in Healthy Subjects (NCT06597799) | Monte Rosa Therapeutics, Inc | 2024-08-07 |
| Study of Oral MRT-2359 in Selected Cancer Patients (NCT05546268) | Monte Rosa Therapeutics, Inc | 2022-10-12 |
Track Monte Rosa Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.